required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.

Takeda Medical Information
This press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development.






_____________________________________________________









Kuykendall A, et al. Rusfertide or Placebo Plus Current Standard of Care Therapy for Polycythemia Vera: Durability of Response and
=*=*=*=*=*=
当前为第21/23页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页